Molecular secrets revealed: antipsychotic docked in its receptor
Discovery may lead to safer, more targeted drugs. Published in Nature and reported in a NIH news reslease, research from the lab of Bryan L. Roth, MD, PhD, revealed the first-ever crystal structure of the dopamine 2 receptor bound to an antipsychotic drug – a much-needed discovery in the quest to create effective drugs with … Read more